Pharmaceutical Technology · 36m
Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
FiercePharma · 5h
Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s Sup | The billionaire family behind former OxyContin maker Purdue Pharma was denied a bankruptcy protection deal in a high-profile Supreme Court ruling last summer.
CT News Junkie · 9h
Purdue, Sackler Family Would Pay $7.4B Under New Opioid Settlement, Tong Says
A $7.4 billion settlement has been reached in principle between states, victims, and members of the Sackler family and Purdue Pharma for their roles in the opioid crisis, Attorney General William Tong said Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results